Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nephron Targets Nationwide Drug Shortage with New Medications | Contract Pharma
Breaking News

Nephron Targets Nationwide Drug Shortage with New Medications

Announces the production of 0.5% Albuterol 5 mL, del Nido Cardioplegia, Lidocaine 1% and Succinylcholine products.

Nephron 503B Outsourcing Facility, a division of Nephron Pharmaceuticals Corp., a company focused on resolving drug shortage concerns, announced the production of 0.5% Albuterol 5 mL, del Nido Cardioplegia, Lidocaine 1% and Succinylcholine products.

The following medications are readily available for order through the Nephron online ordering portal:

• 0.5% Albuterol 25 mg/5 mL (5 mg/mL) Preservative Free
• del Nido Cardioplegia Solution 1000 mL
• Lidocaine Injection Vial, USP 1% 50 mg/5 mL (10 mg/mL) Preservative Free
• Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) Preservative Free

“As a nationwide leader in manufacturing lifesaving medication, we work hard every single day to help the federal government alleviate drug shortages – and to deliver hospitals and patients the treatments they deserve and expect in a timely manner,” said Lou Kennedy, CEO and Owner of Nephron. “Playing this vital role in manufacturing is all the motivation we need to do our jobs well – and stay focused on precisely what it takes to raise the bar not only for our team, but for manufacturers everywhere.”

Nephron provides sterile pharmaceutical manufacturing and operates a 503B Outsourcing Facility division which produces pre-filled sterile syringes, luer-lock vials, IV bottles and IV bags for hospitals across America.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters